Clinical Efficacy of Ruxolitinib in Patients with Myelofibrosis: A Nationwide Population-Based Study in Korea

Previous studies have reported the survival benefit after ruxolitinib treatment in patients with myelofibrosis (MF). However, population-based data of its efficacy are limited. We analyzed the effects of ruxolitinib in MF patients with data from the Korean National Health Insurance Database. In tota...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Byung-Hyun, Moon, Hyemi, Chae, Jae-Eun, Kang, Ka-Won, Kim, Byung-Soo, Lee, Juneyoung, Park, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540308/
https://www.ncbi.nlm.nih.gov/pubmed/34682897
http://dx.doi.org/10.3390/jcm10204774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540308/
https://www.ncbi.nlm.nih.gov/pubmed/34682897
http://dx.doi.org/10.3390/jcm10204774

Ejemplares similares